We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+10.11%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$47.1B
AUM Growth
+$2.61B
Cap. Flow
-$501M
Cap. Flow %
-1.06%
Top 10 Hldgs %
14.43%
Holding
3,576
New
705
Increased
706
Reduced
825
Closed
988

Top Buys

Rank Stock Value
1
WMT icon
Walmart Inc
WMT
+$417M
2
META icon
Meta Platforms (Facebook)
META
+$383M
3
AMZN icon
Amazon
AMZN
+$308M
4
MSFT icon
Microsoft
MSFT
+$293M
5
GE icon
GE Aerospace
GE
+$263M

Top Sells

Rank Stock Value
1
CI icon
Cigna
CI
+$312M
2
BAC icon
Bank of America
BAC
+$292M
3
XOM icon
ExxonMobil
XOM
+$274M
4
LULU icon
lululemon athletica
LULU
+$238M
5
QCOM icon
Qualcomm
QCOM
+$228M

Sector Composition

Rank Sector Weight
1 Healthcare 17.05%
2 Technology 14.35%
3 Consumer Discretionary 13.97%
4 Financials 9.9%
5 Industrials 6.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CFFSW
1851
CALL
DELISTED
CF Acquisition Corp. VII Warrant
CFFSW
$864K ﹤0.01%
83,598
NTR icon
1852
Nutrien
NTR
$33.9B
$864K ﹤0.01%
+11,700
New +$903K
RCEL icon
1853
Avita Medical
RCEL
$137M
$862K ﹤0.01%
61,715
-1,759
-3% -$18.7K
IPAR icon
1854
Interparfums
IPAR
$4.07B
$862K ﹤0.01%
+6,061
New +$747K
MBSC.WS
1855
CALL
DELISTED
M3-Brigade Acquisition III Corp. Public warrants, each whole public warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share
MBSC.WS
$862K ﹤0.01%
83,016
-166,980
-67% -$64.6K
GHL
1856
DELISTED
Greenhill & Co., Inc.
GHL
$860K ﹤0.01%
96,986
-35,131
-27% -$399K
VLN icon
1857
Valens Semiconductor
VLN
$160M
$858K ﹤0.01%
+268,850
New +$1.23M
KOD icon
1858
Kodiak Sciences
KOD
$2.5B
$858K ﹤0.01%
+138,320
New +$968K
GT icon
1859
Goodyear
GT
$2.09B
$855K ﹤0.01%
+77,600
New +$861K
PDSB icon
1860
PDS Biotechnology
PDSB
$37.4M
$855K ﹤0.01%
139,008
+103,376
+290% +$846K
ASTH icon
1861
Astrana Health
ASTH
$1.81B
$852K ﹤0.01%
23,368
+4,768
+26% +$167K
LCAAW
1862
CALL
DELISTED
L Catterton Asia Acquisition Corp Warrant
LCAAW
$848K ﹤0.01%
83,013
-166,983
-67% -$67.7K
BLUA.WS
1863
CALL
DELISTED
BlueRiver Acquisition Corp. Warrants, each whole warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50
BLUA.WS
$847K ﹤0.01%
83,328
HGASW
1864
CALL
DELISTED
Global Gas Corporation Warrant
HGASW
$844K ﹤0.01%
85,317
LNT icon
1865
Alliant Energy
LNT
$18.6B
$844K ﹤0.01%
+15,800
New +$840K
VICR icon
1866
Vicor
VICR
$8.33B
$839K ﹤0.01%
17,879
-5,941
-25% -$330K
SO icon
1867
Southern Company
SO
$108B
$838K ﹤0.01%
12,048
-1,506,542
-99% -$101M
IAT icon
1868
iShares US Regional Banks ETF
IAT
$673M
$834K ﹤0.01%
23,300
+500
+2% +$23.4K
CRMD icon
1869
CorMedix
CRMD
$564M
$834K ﹤0.01%
201,399
+48,024
+31% +$196K
WKME
1870
DELISTED
WalkMe Ltd. Ordinary Shares
WKME
$833K ﹤0.01%
78,303
+65,903
+531% +$672K
XPEV icon
1871
XPeng
XPEV
$12.5B
$830K ﹤0.01%
74,699
-3,800
-5% -$36.7K
NWSA icon
1872
News Corp Class A
NWSA
$15.6B
$827K ﹤0.01%
+47,878
New +$875K
LDTCW
1873
CALL
DELISTED
LeddarTech Holdings Inc. Warrants
LDTCW
$827K ﹤0.01%
83,328
KEN icon
1874
Kenon Holdings
KEN
$3.33B
$826K ﹤0.01%
28,096
+6,006
+27% +$182K
IHF icon
1875
iShares US Healthcare Providers ETF
IHF
$1.22B
$816K ﹤0.01%
16,500
+9,500
+136% +$488K

Similar funds

Marshall Wace's Q1 2023 Portfolio in Review

As of Q1 2023, Marshall Wace held 3,576 positions worth $47.1B, up 5.9% from $44.5B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Marshall Wace's Q1 2023 filing shows 705 new, 706 increased, 825 reduced and 988 closed positions. Its largest new stake was Madrigal Pharmaceuticals: 541,764 shares worth $131M. The largest sale was Cigna, an estimated $312M.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Marshall Wace's largest Q1 2023 buy was Madrigal Pharmaceuticals: 541,764 shares worth $131M.
  • Marshall Wace added most to Walmart Inc in Q1 2023, an estimated $417M increase.
  • Marshall Wace's biggest Q1 2023 reduction was Cigna, cutting an estimated $312M.
  • Marshall Wace fully exited Merck in Q1 2023, selling an estimated $115M.
  • Marshall Wace's ten largest holdings make up 14% of its $47.1B portfolio in Q1 2023.
  • Marshall Wace opened 705 new positions and closed 988 in Q1 2023.
  • Marshall Wace's portfolio value rose 5.9% quarter-over-quarter to $47.1B.

Based on Marshall Wace's 13F filing for Q1 2023, filed 15 May 2023.